Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 18 Oct 2021 |
2 | Reply to Exam Report (MIS-R) | 24 Mar 2022 |
3 | Documents in support of Show cause Hearing (SCH) | 05 Jan 2023 |
1 | EXAMINATION REPORT | 12449542 | 10 Nov 2021 | |
2 | Hearing Notice (Show Cause) | 14371179 | 21 Nov 2022 | |
3 | Hearing Notice (Show Cause) | 15245150 | 15 May 2023 | |
4 | Hearing Notice (Show Cause) | 16728956 | 05 Dec 2023 | |
5 | Hearing Notice (Show Cause) | 17076708 | 09 Jan 2024 | |
6 | Tribunal Refused Notice for : 5176549 | 17293585 | 6516716 | 02 Feb 2024 |
The application for "best" sirolimus eluting coronary stent system was made on 18 October 2021.
The trademark applicant for "best" sirolimus eluting coronary stent system is RELISYS MEDICAL DEVICES.
"best" sirolimus eluting coronary stent system is applied in class(es) 10.
Application for "best" sirolimus eluting coronary stent system is on Refused stage.
Application Id allotted to "best" sirolimus eluting coronary stent system is 5176549.
Trademark agent or attorney for the application is Vrij Kishore Choudhary.
"best" sirolimus eluting coronary stent system filed with the Intellectual property office as a WORD.